These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16706759)

  • 1. Treatment of depression with botulinum toxin A: a case series.
    Finzi E; Wasserman E
    Dermatol Surg; 2006 May; 32(5):645-9; discussion 649-50. PubMed ID: 16706759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facing depression with botulinum toxin: a randomized controlled trial.
    Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
    J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-plane injection of botulinum exotoxin A in glabellar frown lines.
    Ozsoy Z; Gözü A; Genç B
    Aesthetic Plast Surg; 2004; 28(2):114-5. PubMed ID: 15170246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin overrides depression: not surprising, yet sensational.
    Heckmann M; Ceballos-Baumann A
    Dermatol Surg; 2007 Jun; 33(6):765. PubMed ID: 17550462
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm.
    Ochudlo S; Bryniarski P; Opala G
    Parkinsonism Relat Disord; 2007 Dec; 13(8):505-8. PubMed ID: 17543569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
    Smuts JA; Schultz D; Barnard A
    Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
    Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
    Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.
    Wieder JM; Moy RL
    Dermatol Surg; 1998 Nov; 24(11):1172-4. PubMed ID: 9834734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of phantom pain with botulinum-toxin A. A pilot study].
    Kern U; Martin C; Scheicher S; Müller H
    Schmerz; 2003 Apr; 17(2):117-24. PubMed ID: 12695892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM; Gladstone HB
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of Frey's syndrome in patients treated with botulinum toxin type A.
    Luna Ortiz K; Rascon Ortiz M; Sansón Riofrio JA; Villavicencio Valencia V; Mosqueda Taylor A
    Med Oral Patol Oral Cir Bucal; 2007 Jan; 12(1):E79-84. PubMed ID: 17195837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease.
    Koeyers WJ; Van Der Geer S; Krekels G
    J Dermatolog Treat; 2008; 19(4):251-4. PubMed ID: 18629693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.